Ireland
--:--IST
Latest
Clinical Trials in France / NCT06104202
Recruiting Observational

Early Maladaptive Schemas in French Health Care Professionals With Burn Out

NCT06104202 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2024-04-09
Last updated
2026-07-13

Condition(s) studied

Burn Out

Investigational drug(s) / intervention(s)

Early Maladaptive Schemas

Early Maladaptive Schemas: Compare profiles of maladaptive early patterns using scores : * Young Schema Questionnaire Short form * Maslach Burnout Inventory * Montgomery-Asberg depression rating Scale * White Bear Suppression Inventory

Study summary

The purpose of this study is to compare the profiles and domains of maladaptive early schemas in care professionals with burnout symptoms with care professionals without burnout symptoms and with care non-professionals with burnout symptoms.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age ≥ 18 years ; * State of burnout (at least one of the 3 dimensions of the Maslach Burnout Inventory) for care professionals and non-professionals in a state of burnout and absence of a state of burnout for the group of care professionals without a state of burnout; * Membership of a social security scheme; * Patient having been informed and having given his/her oral non-opposition. Exclusion Criteria: * Characterised psychiatric pathology pre-existing the burn out state for the burn out groups and characterised psychiatric pathology for the no burn out group; * Participation in another clinical trial, or in a period of exclusion from another clinical trial; * Participant under guardianship, curatorship or deprived of liberty.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Clinique Mon Repos Écully France Recruiting

More GCS Ramsay Santé pour l'Enseignement et la Recherche trials in France

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06104202 on ClinicalTrials.gov ↗ ← All trials in France